Oral Alterations in Diabetes Mellitus

Open access


Diabetes mellitus is one of the most common chronic diseases which continue to increase in number and significance. It presents the third most prevalent condition among medically compromised patients referring for dental treatment. Diabetes mellitus has been defined as a group of metabolic diseases characterized by hyperglycemia resulting from defects in insulin secretion, insulin action, or both. Hyperglycemia leads to widespread multisystem damage which has an effect on oral tissue. The present article summarizes current knowledge regarding the association between diabetes mellitus and oral and dental health.

If the inline PDF is not rendering correctly, you can download the PDF file here.

  • 1. American Diabetes Association. 2. Classification and Diagnosis of Diabetes. Diabetes Care 2016;39(Suppl 1):S13-22.

  • 2. Wild S Roglic G Green A Sicree R King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27:1047-1053.

  • 3. Guariguata L Whiting DR Hambleton I Beagley J Linnenkamp U Shaw JE. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract 2014;103:137-149.

  • 4. Skamagas M Breen TL LeRoith D. Update on diabetes mellitus: prevention treatment and association with oral diseases. Oral Dis 2008;14:105-114.

  • 5. Schmidt AM Yan SD Wautier JL Stern D. Activation of receptor for advanced glycation end products. A mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis. Circ Res 1999;84:489-497.

  • 6. Ramasamy R Vannucci SJ Yan SS Herold K Yan SF Schmidt AM. Advanced glycation end products and RAGE: a common thread in aging diabetes neurodegeneration and inflammation. Glycobiology 2005;15:16-28.

  • 7. Schmidt AM Hori O Cao R Yan SD Brett J Wautier JL et al. RAGE: A novel cellular receptor for advanced glycation end products. Diabetes 1996;45:S77-80.

  • 8. Stewart CR Obi N Epane EC Akbari AA Halpern L Southerland JH et al. The effects of diabetes on salivary gland protein expression of tetrahydrobiopterin and nitric oxide synthesis and function. J Periodontol 2016;87:735-741.

  • 9. Moore PA Guggenheimer J Etzel KR Weyant RJ Orchard T. Type 1 diabetes mellitus xerostomia and salivary flow rates. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001;92:281-291.

  • 10. Shenoy N Sholapurkar AA Pai KM Adhikari P. Oral health status in geriatric diabetics. Rev Clín Pesq Odontol 2010;6:63-69.

  • 11. Lessa LS Pires PD Ceretta RA Becker IR Ceretta LB Tuon L et al. Meta-analysis of prevalence of xerostomia in diabetes mellitus. Int Arch Med 2015;8:1-13.

  • 12. Cicmil A Govedarica O Lecic J Malis S Cicmil S Cakic S. Oral symptoms and mucosal lesions in patients with diabetes mellitus type 2. Balk J Dent Med 2017;21:50-54.

  • 13. Ittichaicharoen J Chattipakorn N Chattipakorn SC. Is salivary gland function altered in noninsulin-dependent diabetes mellitus and obesity-insulin resistance? Arch Oral Biol 2016;64:61-71.

  • 14. Shirzaiy M Heidari F Dalirsani Z Dehghan J. Estimation of salivary sodium potassium calcium phosphorus and urea in type II diabetic patients. Diabetes Metab Syndr 2015;9:332-336.

  • 15. Kogawa EM Grisi DC Falcão DP Amorim IA Rezende TM da Silva IC et al. Salivary function impairment in type 2 Diabetes patients associated with concentration and genetic polymorphisms of chromogranin A. Clin Oral Invest 2016;62:10-19.

  • 16. Hartman ML Goodson JM Barake R Alsmadi O Al-Mutawa S Ariga J et al. Salivary glucose concentration exhibits threshold kinetics in normal weight overweight and obese children. Diabetes Metab Syndr Obes 2014;8:9-15.

  • 17. Karjalainen KM Knuuttila ML Kaar ML. Salivary factors in children and adolescents with insulin-dependent diabetes mellitus. Pediatr Dent 1996;18:306-311.

  • 18. Seethalakshmi C Reddy RC Asifa N Prabhu S. Correlation of salivary pH incidence of dental caries and periodontal status in diabetes mellitus patients: A cross-sectional study. J Clin Diagn Res 2016;10:ZC12-14.

  • 19. Albert DA Ward A Allweiss P Graves DT Knowler WC Kunzel C et al. Diabetes and oral disease: implications for health professionals. Ann NY Acad Sci 2012;1255:1-15.

  • 20. Negrato CB Tarzia O. Buccal alterations in diabetes mellitus. Diabetol Metabol Syndr 2010;2:3.

  • 21. Oikawa J Ukawa S Ohira H Kawamura T Wakai K Ando M et al. Diabetes mellitus is associated with low secretion rates of immunoglobulin A in saliva. J Epidemiol 2015;25:470-474.

  • 22. Wasalathanthri S Hettiarachchi P Prathapan S. Sweet taste sensitivity in pre-diabetics diabetic and normoglycemic controls: a comparative cross sectional study. BMC Endocr Disord 2014;14:67.

  • 23. Tsujimoto T Imai K Kanda S Kakei M Kajio H Sugiyama T. Sweet taste disorder and vascular complications in patients with abnormal glucose tolerance. Int J Cardiol 2016;221:637-641.

  • 24. Mese H MatsuoR. Salivary secretion taste and hyposalivation. J Oral Rehabil 2007;34:711-723.

  • 25. Gerspach AC Steinert RE Schonenberger L Graber-Maier A Beglinger C. The role of the gut sweet taste receptor in regulating GLP-1 PYY and CCK release in humans. Am J Physiol Endocrinol Metab 2011;301:E317-325.

  • 26. Young RL Chia B Isaacs NJ Ma J Khoo J Wu T et al. Disordered control of intestinal sweet taste receptor expression and glucose absorption in type 2 diabetes. Diabetes 2013;62:3532-3541.

  • 27. Balasubramaniam R Klasser GD Delcanho R. Separating oral burning from burning mouth syndrome: unravelling a diagnostic enigma. Aust Dent J 2009;54:293-299.

  • 28. Maltsman-Tseikhin A Moricca P Niv D. Burning mouth syndrome: will better understanding yield better management? Pain Pract 2007;7:151-162.

  • 29. Javed S Alam U Malik RA. Burning through the pain: treatments for diabetic neuropathy. Diabetes Obes Metab 2015;1:1115-1125.

  • 30. Tesfaye S Boulton AJ Dyck PJ Freeman R Horowitz M Kempler P et al. Toronto Diabetic Neuropathy Expert Group. Diabetic neuropathies: update on definitions diagnostic criteria estimation of severity and treatments. Diabetes Care 2010;33:2285-2293.

  • 31. Gore M Brandenburg NA Dukes E Hoffman DL Tai K-S Stacey B. Pain severity in diabetic peripheral neuropathy is associated with patient functioning symptom levels of anxiety and depression and sleep. J Pain Symptom Manage 2005;30:374-385.

  • 32. Arap A Siqueira SR Silva CB Teixeira MJ Siqueira JT. Trigeminal pain and quantitative sensory testing in painful peripheral diabetic neuropathy. Arch Oral Biol 2010;55:486-493.

  • 33. Casamassimo PS Tucker-Lammertse JE. Diabetic polyradiculopathy with trigeminal nerve involvement; a case report. Oral Surg Oral Med Oral Pathol 1988;66:315-317.

  • 34. Collin HL Niskanen L Uusitupa M Toyry J Collin P Koivisto AM et al. Oral symptoms and signs in elderly patients with type 2 diabetes mellitus. A focus on diabetic neuropathy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2000;90:299-305.

  • 35. Kowall B Holtfreter B Volzke H Schipf S Mundt T Rathmann W et al. Pre-diabetes and well-controlled diabetes are not associated with periodontal disease: the SHIP trend study. J Clin Periodontol 2015;42:422-430.

  • 36. Tsai C Hayes C Taylor G. Glycemic control of type 2 diabetes and severe periodontal disease in the US adult population. Community Dent Oral Epidemiol 2002;30:182-192.

  • 37. Cicmil S Stojanovic N Krunic J Vukotic O Cakic S. Periodontal status in patients suffering from diabetes mellitus in relations to glycosylated hemoglobin level and the level of oral hygiene. Serb Dent J 2010;57:129-133.

  • 38. Taylor JJ Preshaw PM Lalla E. A review of the evidence for pathogenic mechanisms that may link periodontitis and diabetes. J Clin Periodontol 2013;40:S113-134.

  • 39. Preshaw PM Alba AL Herrera D Jepsen S Konstantinidis A Makrilakis K et al. Periodontitis and diabetes: a two-way relationship. Diabetologia 2012;55:21-31.

  • 40. Dandona P Aljada A Bandyopadhyay A. Inflammation: the link between insulin resistance obesity and diabetes. Trends Immunol 2004;25:4-7.

  • 41. Santos VR Lima JA Goncalves TE Bastos MF Figueiredo LC Shibli JA et al. Receptor activator of nuclear factor-kappa B ligand/osteoprotegerin ratio in sites of chronic periodontitis of subjects with poorly and well-controlled type 2 diabetes. J Periodontol 2010;81:1455-1465.

  • 42. Kardesler L Buduneli N Cetinkalp S Kinane DF. Adipokines and inflammatory mediators after initial periodontal treatment in patients with type 2 diabetes and chronic periodontitis. J Periodontol 2010;81:24-33.

  • 43. Lalla E Kaplan S Chang SM Roth GA Celenti R Hinckley K et al. Periodontal infection profiles in type 1 diabetes. J Clin Periodontol 2006;33:855-862.

  • 44. Pradeep AR Raghavendra NM Sharma A Patel SP Raju A Kathariya R et al. Association of serum and crevicularvisfatin levels in periodontal health and disease with type 2 diabetes mellitus. J Periodontol 2012;83:629-634.

  • 45. Battaglia M. Neutrophils and type 1 autoimmune diabetes. Curr Opin Hematol 2014;21:8-15.

  • 46. Borgnakke WS Ylöstalo PV Taylor GW Genco RJ. Effect of periodontal disease on diabetes: systematic review of epidemiologic observational evidence. J Clin Periodontol 2013;40:S135-152.

  • 47. Taylor GW Borgnakke WS. Periodontal disease: Associations with diabetes glycemic control and complications. Oral Dis 2008;14:191-203.

  • 48. Mealey BL Rose LF. Diabetes mellitus and inflammatory periodontal disease. Curr Opin Endocrinol Diabetes Obes 2008;15:135-141.

  • 49. Engebretson S Kocher T. Evidence that periodontal treatment improves diabetes outcomes: a systematic review and meta-analysis. J Periodontol 2013;84:S153-169.

  • 50. Simpson TC Weldon JC Worthington HV Needleman I Wild SH Moles DR et al. Treatment of periodontal disease for glycaemic control in people with diabetes mellitus. Cochrane Database Syst Rev 2015;11:CD004714.

  • 51. Sanitá PV Pavarina AC Giampaolo ET Silva MM Mima EG Ribeiro DG et al. Candida spp. prevalence in well controlled type 2 diabetic patients with denture stomatitis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2011;111:726-733.

  • 52. Bastos AS Leite AR Spin-Neto R Nassar PO Massa Couto EM Orrico SR. Diabetes mellitus and oral mucosa alterations: prevalence and risk factors. Diabetes Res Clin Pract 2011;92:100-105.

  • 53. Dikshit RP Ramadas K Hashibe M Thomas G Somanathan T Sankaranarayanan R. Association between diabetes mellitus and pre-malignant oral diseases: across sectionalstudy in Kerala India. Int J Cancer 2006;118:453-457.

  • 54. Beikler T Flemmig TF. Implants in the medically compromised patient. Crit Rev Oral Biol Med 2003;14:305-316.

  • 55. Catanzaro O Dziubecki D Lauria LC Ceron CM Rodriguez RR. Diabetes and its effects on dental pulp. J Oral Sci 2006;48:195-199.

  • 56. Claudino M Nunes IS Gennaro G Cestari TM Spadella CT Garlet GP et al. Diabetes triggers the loss of tooth structure associated to radiographical and histological dental changes and its evolution to progressive pulp and periapical lesions in rats. Arch Oral Biol 2015;60:1690-1698.

  • 57. Leite MF Ganzerla E Marques MM Nicolau J. Diabetes induces metabolic alterations in dental pulp. J Endod 2008;34:1211-1214.

  • 58. Ilić J Radović K Roganović J Brković B Stojić D. The levels of vascular endothelial growth factor and bone morphogenetic protein 2 in dental pulp tissue of healthy and diabetic patients. J Endod 2012;38:764-768.

  • 59. Garber SE Shabahang S Escher AP Torabinejad M. The effect of hyperglycemia on pulpal healing in rats. J Endod 2009;35:60-62.

  • 60. Nichols MS Shaw JH. The effect of alloxan diabetes on caries incidence in the albino rat. J Dent Res 1957;36:68-74.

  • 61. Arheiam A Omar S. Dental caries experience and periodontal treatment needs of 10- to 15-year old children with type 1 diabetes mellitus. Int Dent J 2014;64:150-154.

  • 62. Bakhshandeh S Murtomaa H Vehkalahti MM Mofid R Suomalainen K. Dental findings in diabetic adults. Caries Res 2008;42:14-18.

  • 63. Stojanović N Krunić J Cicmil S Vukotić O. Oral health status in patients with diabetes mellitus type 2 in relation to metabolic control of the disease. Srp Arh Celok Lek 2010;138:420-424.

  • 64. El-Tekeya M El Tantawi M Fetouh H Mowafy E Abo Khedr N. Caries risk indicators in children with type 1 diabetes mellitus in relation to metabolic control. Pediatr Dent 2012;34:510-516.

  • 65. Iwama A Nishigaki N Nakamura K Imaizumi I Shibata N Yamasaki M et al. The effect of high sugar intake on the development of periradicular lesions in rats with type 2 diabetes. J Dent Res 2003;82:322-325.

  • 66. López-López J Jané-Salas E Estrugo-Devesa A Velasco- Ortega E Martín-González J Segura-Egea JJ. Periapical and endodontic status of type 2 diabetic patients in Catalonia Spain: a cross-sectional study. J Endod 2011;37:598-601.

  • 67. Sánchez-Domínguez B López-López J Jané-Salas E Castellanos-Cosano L Velasco-Ortega E Segura-Egea JJ. Glycated haemoglobin levels and prevalence of apical periodontitis in type 2 diabetic patients. J Endod 2015;41:601-606.

  • 68. Britto LR Katz J Guelmann M Heft M. Periradicular radiographic assessment in diabetic and control individuals. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2003;96:449-452.

  • 69. Khalighinejad N Aminoshariae MR Aminoshariae A Kulild JC Mickel A Fouad AF. Association between systemic diseases and apical periodontitis. J Endod 2016;42:1427-1434.

  • 70. Fouad AF Burleson J. The effect of diabetes mellitus on endodontic treatment outcome: data from an electronic patient record. J Am Dent Assoc 2003;134:43-51.

  • 71. Segura-Egea JJ Martín-González J Cabanillas-Balsera D Fouad AF Velasco-Ortega E López-López J. Association between diabetes and the prevalence of radiolucent periapical lesions in root-filled teeth: systematic review and meta-analysis. Clin Oral Investig 2016;20:1133-1141.

  • 72. Astolphi RD Curbete MM Colombo NH Shirakashi DJ Chiba FY Prieto AK et al. Periapical lesions decrease insulin signal and cause insulin resistance. J Endod 2013;39:648-652.

  • 73. Cintra LT da Silva Facundo AC Azuma MM Sumida DH Astolphi RD Bomfim SR et al. Pulpal and periodontal diseases increase triglyceride levels in diabetic rats. Clin Oral Investig 2013;17:1595-1599.

  • 74. Cintra LT Samuel RO Facundo AC Prieto AK Sumida DH Bomfim SR et al. Relationships between oral infections and blood glucose concentrations or HbA1c levels in normal and diabetic rats. Int Endod J 2014;47:228-237.

  • 75. Cintra LT Samuel RO Azuma MM Ribeiro CP Narciso LG de Lima VM et al. Apical periodontitis and periodontal disease increase serum IL-17 levels in normoglycemic and diabetic rats. Clin Oral Investig 2014;18:2123-2128.

  • 76. Lalla E Cheng B Kunzel C Burkett S Lamster IB. Dental findings and identification of udiagnosed hyperglycemia. J Dent Res 2013;92:888-892.

Journal information
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 668 348 18
PDF Downloads 277 144 6